Celltrion Pharm Inc Net Asset Quality Index
Celltrion Pharm Inc net asset quality index. Celltrion Pharm Inc (068760) has a Net Asset Quality Index of 57.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩745.80 Billion minus total liabilities of ₩319.38 Billion yields net assets of ₩426.42 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 068760 net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Celltrion Pharm Inc (2011–2024)
Net asset quality index of Celltrion Pharm Inc from 2011 to 2024. This chart shows how Celltrion Pharm Inc's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 57.2%, representing net assets of ₩426.42 Billion against total assets of ₩745.80 Billion KRW. Check asset allocation strategy of Celltrion Pharm Inc to assess the company's strategic physical and investment asset allocation.
Celltrion Pharm Inc Net Asset Quality Index by Year (2011–2024)
Celltrion Pharm Inc net asset quality index by year from 2011 to 2024. The table below presents the year-by-year Net Asset Quality Index for Celltrion Pharm Inc from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 068760 company net worth.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 59.3% | ₩396.92 Billion | ₩669.46 Billion | ₩272.54 Billion | ▲ +0.6 pp |
| 2023 | 58.7% | ₩376.67 Billion | ₩641.64 Billion | ₩264.98 Billion | ▼ -0.8 pp |
| 2022 | 59.5% | ₩356.79 Billion | ₩599.72 Billion | ₩242.94 Billion | ▲ +7.4 pp |
| 2021 | 52.0% | ₩331.97 Billion | ₩637.88 Billion | ₩305.92 Billion | ▼ -2.8 pp |
| 2020 | 54.8% | ₩300.56 Billion | ₩548.07 Billion | ₩247.51 Billion | ▼ -4.6 pp |
| 2019 | 59.5% | ₩280.03 Billion | ₩470.98 Billion | ₩190.95 Billion | ▼ -0.2 pp |
| 2018 | 59.7% | ₩270.03 Billion | ₩452.44 Billion | ₩182.41 Billion | ▼ -2.8 pp |
| 2017 | 62.4% | ₩293.62 Billion | ₩470.27 Billion | ₩176.65 Billion | ▼ -5.1 pp |
| 2016 | 67.6% | ₩344.65 Billion | ₩510.02 Billion | ₩165.37 Billion | ▲ +17.0 pp |
| 2015 | 50.6% | ₩236.23 Billion | ₩466.77 Billion | ₩230.54 Billion | ▼ -1.5 pp |
| 2014 | 52.2% | ₩214.43 Billion | ₩411.16 Billion | ₩196.74 Billion | ▲ +5.5 pp |
| 2013 | 46.6% | ₩168.41 Billion | ₩361.35 Billion | ₩192.94 Billion | ▼ -0.9 pp |
| 2012 | 47.5% | ₩157.25 Billion | ₩331.04 Billion | ₩173.80 Billion | ▼ -11.9 pp |
| 2011 | 59.4% | ₩128.27 Billion | ₩216.08 Billion | ₩87.81 Billion | — |